Molecular mechanisms of targeted cancer treatments
Description: 1-day course covering a wide range of licensed and experimental cancer treatments, explaining their mechanism of action at a molecular and cellular level. Treatments described include: growth factor receptor inhibitors, kinase inhibitors, monoclonal antibodies, PARP inhibitors, ALK inhibitors, CDK inhibitors, immunotherapies.
Audience: Ideal for pharmacists, scientifically-minded nurses, pharmaceutical companies, junior doctors
To book, contact: email@example.com
View the programme